Key Takeaways from Studies on Depo-Provera and Its Health Risks
Bone Density Studies: Long-term use of Depo-Provera has been associated with significant bone mineral density loss, increasing the risk of osteoporosis and fractures.
Cancer Risk Research: Some studies suggest a potential link between Depo-Provera and an increased risk of breast cancer, particularly in younger women.
Endocrine Disruption: Depo-Provera’s synthetic progestin affects hormone levels, which may contribute to long-term reproductive and metabolic health issues.
FDA Warnings: The FDA issued a Black Box Warning about the risk of bone loss, advising against prolonged use beyond two years unless no other options are available.
Legal Action: Lawsuits allege that manufacturers failed to adequately warn users about the serious health risks associated with long-term use of Depo-Provera.